South Africa Rolls Out 96% Effective HIV Prevention Shot

When a Health-e News journalist walked into Maria Rantho Community Health Centre in Soshanguve to report on South Africa's revolutionary new HIV prevention program, she never expected to become part of the story herself.

South Africa launched a nationwide rollout of Lenacapavir this week, an injection proven more than 96% effective at preventing HIV with just two shots per year. President Cyril Ramaphosa announced the program last week, designating 360 clinics across six provinces to offer this game-changing pre-exposure prophylaxis (PrEP).

The journalist visited clinics in Gauteng province, where 133 of the designated sites are located. At Maria Rantho, the clean facilities, friendly staff, and short wait times convinced her to get in line herself, despite a lifelong terror of needles.

The process took about 15 minutes from start to finish. A counselor asked about her HIV status and sexual history in a calming, nonjudgmental way before explaining the simple procedure: get tested, and if negative, get the shot.

After her test came back negative, a nursing assistant checked her vitals and opened her medical file. Then came the hard part for someone who panics at the sight of needles.

The nurse showed remarkable compassion when she saw the journalist's fear. She explained the package contained two injections and four pills: two to take immediately after the shots, and two more after 24 hours.

Two nurses helped her through it, one administering the injections while the other held her hand and encouraged her to close her eyes. The journalist screamed when the first needle touched her skin but made it through both shots.

The clinic required a 30-minute observation period to watch for any adverse reactions. The nurse reminded her that after taking the final two pills the next day, she'd be protected and free to resume normal activities.

Why This Inspires

South Africa records around 170,000 new HIV infections every year. This two-shot-per-year prevention method removes major barriers that made daily oral PrEP difficult for many people to maintain consistently.

The journalist's hands swelled after the injections, but by the next morning, the pain had nearly disappeared. Her willingness to face her fear mirrors the courage of thousands of South Africans now protecting themselves with this breakthrough prevention tool.

Anyone can assess their own risk and choose to receive Lenacapavir, regardless of whether they belong to traditionally high-risk populations. The nationwide rollout represents hope for dramatically reducing new infections across the country.

South Africa is leading the way in making cutting-edge HIV prevention accessible to everyone who needs it.